BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 27297851)

  • 1. A randomized controlled trial of levosimendan to reduce mortality in high-risk cardiac surgery patients (CHEETAH): Rationale and design.
    Zangrillo A; Alvaro G; Pisano A; Guarracino F; Lobreglio R; Bradic N; Lembo R; Gianni S; Calabrò MG; Likhvantsev V; Grigoryev E; Buscaglia G; Pala G; Auci E; Amantea B; Monaco F; De Vuono G; Corcione A; Galdieri N; Cariello C; Bove T; Fominskiy E; Auriemma S; Baiocchi M; Bianchi A; Frontini M; Paternoster G; Sangalli F; Wang CY; Zucchetti MC; Biondi-Zoccai G; Gemma M; Lipinski MJ; Lomivorotov VV; Landoni G
    Am Heart J; 2016 Jul; 177():66-73. PubMed ID: 27297851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic milrinone for the prevention of low cardiac output syndrome and mortality in children undergoing surgery for congenital heart disease.
    Burkhardt BE; Rücker G; Stiller B
    Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD009515. PubMed ID: 25806562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levosimendan in Patients with Left Ventricular Dysfunction Undergoing Cardiac Surgery: An Update Meta-Analysis and Trial Sequential Analysis.
    Wang B; He X; Gong Y; Cheng B
    Biomed Res Int; 2018; 2018():7563083. PubMed ID: 29854789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An efficacy and mechanism evaluation study of Levosimendan for the Prevention of Acute oRgan Dysfunction in Sepsis (LeoPARDS): protocol for a randomized controlled trial.
    Orme RM; Perkins GD; McAuley DF; Liu KD; Mason AJ; Morelli A; Singer M; Ashby D; Gordon AC
    Trials; 2014 Jun; 15():199. PubMed ID: 24894386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Preoperative Infusion of Levosimendan on Biomarkers of Myocardial Injury and Haemodynamics After Paediatric Cardiac Surgery: A Randomised Controlled Trial.
    Abril-Molina A; Gómez-Luque JM; Perin F; Esteban-Molina M; Ferreiro-Marzal A; Fernandez-Guerrero C; Ocete-Hita E
    Drugs R D; 2021 Mar; 21(1):79-89. PubMed ID: 33367965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative levosimendan decreases mortality and the development of low cardiac output in high-risk patients with severe left ventricular dysfunction undergoing coronary artery bypass grafting with cardiopulmonary bypass.
    Levin R; Degrange M; Del Mazo C; Tanus E; Porcile R
    Exp Clin Cardiol; 2012 Sep; 17(3):125-30. PubMed ID: 23620700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative Levosimendan in Patients With Severe Left Ventricular Dysfunction Undergoing Isolated Coronary Artery Bypass Grafting: A Meta-Analysis of Randomized Controlled Trials.
    Ayala R; Gewehr DM; Godoi A; Velasquez C; Fernandez M; Carvalho PEP; Goebel N
    J Cardiothorac Vasc Anesth; 2024 Mar; 38(3):649-659. PubMed ID: 38228424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of timing of Levosimendan administration on outcomes in cardiac surgery.
    Schiefenhövel F; Berger C; Penkova L; Grubitzsch H; Haller B; Meyer A; Heringlake M; Sander M; Erb JM; Balzer F; Treskatsch S
    Front Cardiovasc Med; 2023; 10():1213696. PubMed ID: 37564910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Levosimendan Versus Milrinone After the Arterial Switch Operation for Infants ≤3 kg.
    Joshi RK; Joshi R; Aggarwal N; Agarwal M; Siddartha CR; Relan J; Kumar A; Modi M; Chug P
    World J Pediatr Congenit Heart Surg; 2024 May; ():21501351241239306. PubMed ID: 38766718
    [No Abstract]   [Full Text] [Related]  

  • 10. Dexamethasone in pEdiatric Cardiac Surgery (DECiSion): Rationale and design of a randomized controlled trial.
    Ponomarev D; Boboshko V; Shmyrev V; Kornilov I; Bondarenko I; Soynov I; Voytov A; Polyanskih S; Strunin O; Bogachev A; Landoni G; Neto CN; Nicolau GO; Wen Z; Evdokimov M; Sulejmanov S; Chernogrivov A; Karaskov A; Lomivorotov V
    Contemp Clin Trials; 2018 Sep; 72():16-19. PubMed ID: 30016720
    [No Abstract]   [Full Text] [Related]  

  • 11. [Low Output Syndrome:Points to Consider for Intraoperative Myocardial Protection and Treatment Methods].
    Suzuki F; Kamiya H
    Kyobu Geka; 2023 Sep; 76(10):751-755. PubMed ID: 38056831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levosimendan for Hemodynamic Support after Cardiac Surgery.
    Landoni G; Lomivorotov VV; Alvaro G; Lobreglio R; Pisano A; Guarracino F; Calabrò MG; Grigoryev EV; Likhvantsev VV; Salgado-Filho MF; Bianchi A; Pasyuga VV; Baiocchi M; Pappalardo F; Monaco F; Boboshko VA; Abubakirov MN; Amantea B; Lembo R; Brazzi L; Verniero L; Bertini P; Scandroglio AM; Bove T; Belletti A; Michienzi MG; Shukevich DL; Zabelina TS; Bellomo R; Zangrillo A;
    N Engl J Med; 2017 May; 376(21):2021-2031. PubMed ID: 28320259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levosimendan in Patients with Left Ventricular Dysfunction Undergoing Cardiac Surgery.
    Mehta RH; Leimberger JD; van Diepen S; Meza J; Wang A; Jankowich R; Harrison RW; Hay D; Fremes S; Duncan A; Soltesz EG; Luber J; Park S; Argenziano M; Murphy E; Marcel R; Kalavrouziotis D; Nagpal D; Bozinovski J; Toller W; Heringlake M; Goodman SG; Levy JH; Harrington RA; Anstrom KJ; Alexander JH;
    N Engl J Med; 2017 May; 376(21):2032-2042. PubMed ID: 28316276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levosimendan in patients with left ventricular systolic dysfunction undergoing cardiac surgery on cardiopulmonary bypass: Rationale and study design of the Levosimendan in Patients with Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery Requiring Cardiopulmonary Bypass (LEVO-CTS) trial.
    Mehta RH; Van Diepen S; Meza J; Bokesch P; Leimberger JD; Tourt-Uhlig S; Swartz M; Parrotta J; Jankowich R; Hay D; Harrison RW; Fremes S; Goodman SG; Luber J; Toller W; Heringlake M; Anstrom KJ; Levy JH; Harrington RA; Alexander JH;
    Am Heart J; 2016 Dec; 182():62-71. PubMed ID: 27914501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Levosimendan on Low Cardiac Output Syndrome in Patients With Low Ejection Fraction Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass: The LICORN Randomized Clinical Trial.
    Cholley B; Caruba T; Grosjean S; Amour J; Ouattara A; Villacorta J; Miguet B; Guinet P; Lévy F; Squara P; Aït Hamou N; Carillion A; Boyer J; Boughenou MF; Rosier S; Robin E; Radutoiu M; Durand M; Guidon C; Desebbe O; Charles-Nelson A; Menasché P; Rozec B; Girard C; Fellahi JL; Pirracchio R; Chatellier G;
    JAMA; 2017 Aug; 318(6):548-556. PubMed ID: 28787507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein C zymogen in severe sepsis: a double-blinded, placebo-controlled, randomized study.
    Pappalardo F; Crivellari M; Di Prima AL; Agracheva N; Celinska-Spodar M; Lembo R; Taddeo D; Landoni G; Zangrillo A
    Intensive Care Med; 2016 Nov; 42(11):1706-1714. PubMed ID: 27344436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale and design of the multicenter randomized trial investigating the effects of levosimendan pretreatment in patients with low ejection fraction (≤40 %) undergoing CABG with cardiopulmonary bypass (LICORN study).
    Caruba T; Hourton D; Sabatier B; Rousseau D; Tibi A; Hoffart-Jourdain C; Souag A; Freitas N; Yjjou M; Almeida C; Gomes N; Aucouturier P; Djadi-Prat J; Menasché P; Chatellier G; Cholley B
    J Cardiothorac Surg; 2016 Aug; 11(1):127. PubMed ID: 27496105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative Effect of Levosimendan and Milrinone in Cardiac Surgery Patients With Pulmonary Hypertension and Left Ventricular Dysfunction.
    Mishra A; Kumar B; Dutta V; Arya VK; Mishra AK
    J Cardiothorac Vasc Anesth; 2016 Jun; 30(3):639-46. PubMed ID: 27321790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levosimendan for patients with severely reduced left ventricular systolic function and/or low cardiac output syndrome undergoing cardiac surgery: a systematic review and meta-analysis.
    Sanfilippo F; Knight JB; Scolletta S; Santonocito C; Pastore F; Lorini FL; Tritapepe L; Morelli A; Arcadipane A
    Crit Care; 2017 Oct; 21(1):252. PubMed ID: 29047417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of prophylactic administration of Levosimendan on short-term and long-term outcome in high-risk patients with severely reduced left-ventricular ejection fraction undergoing cardiac surgery - a retrospective analysis.
    Grieshaber P; Lipp S; Arnold A; Görlach G; Wollbrück M; Roth P; Niemann B; Wilhelm J; Böning A
    J Cardiothorac Surg; 2016 Dec; 11(1):162. PubMed ID: 27906091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.